Impact Of Inflation And Strict Drug Pricing Will Limit Profits For Drugmakers Operating In South Africa
Pharmaceuticals / South Africa / Fri 13 Jan, 2023
Key View
- The minor increase to the Single Exit Price (SEP) for 2023 will limit pharmaceutical market growth in South Africa.
- High energy prices and inflation will squeeze drugmakers profits in the short-term.
- We expect pharmaceutical industry bodies to challenge the current SEP increase for 2023.
The minor increase to the Single Exit Price